Daniel K.
Zamówienie bez problemów, mail z potwierdzeniem przyszedł od razu.
13 August 2026
Before and after
A visible change over time
Tirzepatide
Dual support for weight management
Before and after
A visible change over time
Dual support for weight management
Less hunger. Easier portions. More consistency.
Tirzepatide offers a practical direction for weight management: less appetite, earlier satiety and an easier way to follow planned meals. This may make everyday progress more structured and consistent.
Appetite and metabolic control
A dual GIP and GLP-1 direction
Two complementary pathways connected with satiety, appetite and glucose control.
Size
In stock
8.04€ per mg
Bought 692 times in the last 30 days
Delivery and returns
Dispatch
Ordered before 13:00 — the same working day
Delivery
Tracked delivery, 2–5 working days
Key objectives
Tirzepatide focuses on everyday barriers: hunger between meals, oversized portions and difficulty following a plan consistently.
Support for the signal that helps a meal end sooner and reduces between-meal snacking.
Less pressure from appetite may make planned amounts of food easier to maintain.
A direction focused on gradual change built through regular decisions.
The dual pathway also considers the body's glucose response after a meal.
Tirzepatide combines activity associated with two incretin pathways, GIP and GLP-1. This makes it a popular choice for comparative research into satiety, appetite control, glucose response and broader metabolic balance.
Available 10 mg and 20 mg options make it easier to match the amount of material to the project. Every batch of lyophilisate has analytical documentation. The product is for research only and is not a medicine.
Form: lyophilised powder, white to off-white, in a glass vial closed with a butyl rubber stopper and an aluminium seal. Available variants: a 10 mg vial and a 20 mg vial of peptide. Purity: not less than 99 % by HPLC with UV detection, identity confirmed by mass spectrometry.
Each vial label states the substance name, net mass, batch number and production date, and the batch number points to the certificate of analysis. Ships from a warehouse in Poland, packed to protect against mechanical damage.
Store sealed vials of lyophilisate at −20 °C, away from light and moisture. The dry peptide is considerably more durable than the peptide in solution, so reconstitute only as much material as the current run of assays requires.
The standard solvent in laboratory work is bacteriostatic water, added slowly down the wall of the vial and never directly onto the cake. Swirl the vial gently until fully dissolved – do not shake and do not vortex at high speed, because acylated peptides of this mass foam and aggregate readily. Keep the solution at 2–8 °C, shielded from light; for longer storage divide it into aliquots.
This product is intended for research and laboratory purposes only. It is not a medicinal product, a food supplement, a cosmetic or a medical device, and it is not approved for use in humans or in animals. It is not suitable for consumption, for administration by any route, or for diagnostic or therapeutic purposes.
The material does not replace any authorised medicinal product containing the same substance. The reagent is intended for qualified laboratory personnel working with personal protective equipment. Keep out of the reach of children.
Tirzepatide at a glance
Tirzepatide combines activity at GIP and GLP-1 receptors. This dual mechanism focuses on common barriers to weight reduction: strong appetite, limited satiety and difficulty maintaining a plan.
A dual GIP/GLP-1 agonist
One molecule acting on two incretin pathways connected with satiety, insulin secretion and glucose control.
Two complementary directions
GLP-1 supports satiety and appetite control, while GIP adds another signal connected with the metabolic response after a meal.
A dual approach
Tirzepatide combines two incretin pathways to support appetite and a more structured metabolic response. In everyday terms, this may create more room for mindful portions and consistency.
Less snacking
A longer feeling of fullness may reduce the urge to eat between planned meals.
Better control
Lower appetite can make it easier to align food amounts with real needs and a plan.
A dual signal
The GIP and GLP-1 combination includes appetite and the glucose response after meals.
How to understand it
The dual GIP/GLP-1 signal supports satiety and metabolic response, while the practical outcome may be an easier way to follow a nutrition plan.
Signal
Two meal-responsive incretin pathways create a connected starting point.
Everyday life
Less hunger may make it easier to finish meals sooner and reduce snacking.
Direction
The path to change
The full picture of change
Tirzepatide does not replace nutrition, movement or medical care. Its concept is to make lifestyle work more manageable through better appetite control and a steadier approach to the goal.
Balanced meals and adequate protein help establish habits that can last.
Regular movement supports fitness, function and a healthier everyday routine.
Important to know
Tirzepatide acts at GIP and GLP-1 receptors, bringing two incretin pathways together.
Appetite control supports the process but does not replace nutrition, movement and consistency.
The pace of change, tolerance and individual needs may differ.
This information is educational and does not replace individual medical advice.
Mechanism
Research describes the two pathways separately: GLP-1 in the context of satiety signalling, GIP in the context of insulin sensitivity.
Research applications
4.8
Based on 21 reviews
Latest 5 of 21
Daniel K.
Zamówienie bez problemów, mail z potwierdzeniem przyszedł od razu.
13 August 2026
Monika R.
Każda fiolka jest czytelnie oznaczona i starannie przygotowana — właśnie tego szukałem.
26 July 2026
Adam H.
Kontakt z obsługą szybki, a odpowiedzi konkretne, nie ogólnikowe.
8 July 2026
Weronika P.
Dobrze zabezpieczone: pudełko zewnętrzne, folia bąbelkowa, a w środku formowana wkładka.
20 June 2026
Filip N.
Dostawa zajęła trzy dni zamiast spodziewanych dwóch, poza tym bez zastrzeżeń.
2 June 2026
Leave a review
Tell the next buyer what arrived: the packaging, the labelling, the documentation, the delivery. Please do not describe effects — this material is not sold for use.
GLP-1 pathway
(4.9)
from73.52€98.87€
A research material associated with appetite regulation, satiety, glucose balance and metabolism.
Cellular metabolism
(4.8)
from91.95€
A key coenzyme for projects exploring cellular energy, metabolism and ageing-related processes.
Metabolism
(4.8)
from32.03€
A mitochondrial peptide for research into cellular energy, metabolism and adaptation to physical strain.
GLP-1 + GIP + glucagon
(4.8)
from103.48€149.57€
A research material for projects on appetite, satiety and metabolism, combining three research pathways in one molecule.
Solvent
(4.9)
from3.46€
A practical laboratory solvent with 0.9% benzyl alcohol for preparing lyophilised materials.
Neuro & memory
(4.9)
from18.21€
A research peptide associated with focus, memory, learning and nerve-cell protection.
Skin & collagen
(4.7)
25.12€
A copper peptide for research into skin condition, collagen, elasticity and renewal processes.
Recovery
(4.8)
45.86€
A convenient two-peptide blend for research into tissue repair, mobility and renewal processes.
Questions
Answers to the questions that matter before ordering this position.
BeforeAfter−35 kg
BeforeAfter−32 kg
Nutrition, movement and consistency create conditions for gradual weight reduction.
A realistic plan and progress monitoring help maintain a chosen direction.
The best plan is one that can be discussed safely with a qualified professional and followed consistently.
BeforeAfter−33 kg
BeforeAfter−34 kg
The photographs and figures come from a demonstration layout. Individual results may vary.
